ATA-28234-92106
2 vaccinations
4 coded responses
10 check-ins
4 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 303 / GA
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- ABD-92048-50007
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Dose 1 — Moderna
-
2022-06-23
Registered in v-safe
-
2022-06-24
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Runny nose and cough. Assuming unrelated.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-24
Report sent to call center — days 1–6 daily, dose 1, under 3Be unable to attend daycare/school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-25
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · FeverFree text: Cough & runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-06-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-06-28
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny nose ongoing for a few daysMedDRA releases: 2024-11 · check-in free text available
- 2022-07-06
-
2022-07-20
Dose 2 — Moderna
-
2022-07-22
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-23
-
2022-07-24
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Fever · Irritability/cryingUnder 3 check-in
-
2022-07-29
Health check-in — day 7, dose 2, under 3Feeling: Fair · Fever · Sleepiness, Irritability/crying · Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-08-12
-
2022-08-23
Survey response — day 28, dose 2, under 3MedDRA: Cough, Ear infection, Respiratory syncytial virus infection, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RSV and ear infection. Cough, runny nose, congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-23
Report sent to call center — day 28, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
| 2 | 2022-07-20 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Runny nose and cough. Assuming unrelated.
Systemic reaction (other): Cough & runny nose
Systemic reaction (other): Runny nose ongoing for a few days
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: RSV and ear infection. Cough, runny nose, congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release